share_log

We Think That There Are More Issues For Haohua Chemical Science & Technology (SHSE:600378) Than Just Sluggish Earnings

We Think That There Are More Issues For Haohua Chemical Science & Technology (SHSE:600378) Than Just Sluggish Earnings

我们认为,昊华化学科技(SHSE: 600378)面临的问题不仅仅是收益疲软
Simply Wall St ·  05/06 02:55

A lackluster earnings announcement from Haohua Chemical Science & Technology Corp., Ltd. (SHSE:600378) last week didn't sink the stock price. However, we believe that investors should be aware of some underlying factors which may be of concern.

昊华化学科技股份有限公司(SHSE: 600378)上周公布的财报乏善可陈,但并未使股价下跌。但是,我们认为,投资者应注意一些可能令人担忧的潜在因素。

earnings-and-revenue-history
SHSE:600378 Earnings and Revenue History May 6th 2024
SHSE: 600378 收益和收入历史记录 2024 年 5 月 6 日

The Impact Of Unusual Items On Profit

不寻常物品对利润的影响

For anyone who wants to understand Haohua Chemical Science & Technology's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥83m worth of unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. Which is hardly surprising, given the name. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

对于任何想了解昊华化学科技超出法定数字的利润的人来说,值得注意的是,在过去的十二个月中,从价值8300万元人民币的不寻常物品中获得了法定利润。我们不能否认更高的利润通常会让我们感到乐观,但如果利润是可持续的,我们更愿意这样做。当我们分析全球绝大多数上市公司时,我们发现重大不寻常的事项往往不会重演。考虑到这个名字,这并不奇怪。假设这些不寻常的项目在本年度不会再次出现,因此我们预计明年的利润将疲软(也就是说,在业务没有增长的情况下)。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

这可能会让你想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看根据他们的估计描绘未来盈利能力的交互式图表。

Our Take On Haohua Chemical Science & Technology's Profit Performance

我们对昊华化学科技盈利表现的看法

Arguably, Haohua Chemical Science & Technology's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Haohua Chemical Science & Technology's true underlying earnings power is actually less than its statutory profit. But at least holders can take some solace from the 13% per annum growth in EPS for the last three. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Haohua Chemical Science & Technology as a business, it's important to be aware of any risks it's facing. Case in point: We've spotted 1 warning sign for Haohua Chemical Science & Technology you should be aware of.

可以说,浩华化学科技的法定收益被提高利润的不寻常项目所扭曲。因此,在我们看来,皓华化学科技的真正潜在盈利能力实际上可能低于其法定利润。但是,至少持有人可以从过去三年的每股收益每年增长13%中得到一些安慰。本文的目标是评估我们在多大程度上可以依靠法定收益来反映公司的潜力,但还有很多需要考虑的地方。如果您想进一步了解浩华化学科技作为一家企业,请务必了解其面临的任何风险。一个很好的例子:我们发现了你应该注意的皓华化学科技的1个警告信号。

Today we've zoomed in on a single data point to better understand the nature of Haohua Chemical Science & Technology's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

今天,我们放大了单个数据点,以更好地了解昊华化学科技利润的性质。但是,还有很多其他方法可以让你对公司的看法。有些人认为高股本回报率是优质业务的好兆头。虽然可能需要你进行一些研究,但你可能会发现这份免费收集的拥有高股本回报率的公司,或者这份内部人士正在购买的股票清单很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发